Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Exane BNP Paribas Initiates Coverage On Steven Madden with Outperform Rating

Exane BNP Paribas Initiates Coverage On Steven Madden with Outperform Rating

Exane BNP Paribas analyst Aubrey Tianello initiates coverage on Steven Madden (NASDAQ:SHOO) with a Outperform rating.

byBenzinga Newsdesk

September 21, 2022

1 minute read

Exane BNP Paribas analyst Aubrey Tianello initiates coverage on Steven Madden (NASDAQ:SHOO) with a Outperform rating.

Stifel Maintains Buy on Apellis Pharmaceuticals, Raises Price Target to $75

By Benzinga Newsdesk

February 21, 8:59 AM

Stifel analyst Annabel Samimy maintains Apellis Pharmaceuticals (NASDAQ:APLS) with a Buy and raises the price target from $65 to $75.

APLS

Nano Dimension Announces Preliminary Q2/2023 Revenue Of $14.8M, A 33% Increase YoY

By Happy Mohamed

July 6, 8:45 AM

Revenue of $14.8 million for Q2/2023 - 33% Increase Over Q2/2022 Revenue of $29.7 million for H1/2023 - 38% Increase Over H1/2022 Waltham, Massachusetts, July

NNDM

Chembio Diagnostics Files For Potential Stock Offering, Size Not Disclosed

By Michael Horton

September 7, 5:22 PM

-Reuters

CEMI

Friend.Tech Launches Version 2 With Native Token Airdrop, But Not Everything Goes According To Plan…

By Murtuza Merchant

May 3, 10:22 AM

Decentralized social platform Friend.Tech made a splash on Friday with the launch of its highly anticipated version 2 and the airdrop of its native token.

ETH

Exane BNP Paribas Initiates Coverage On Steven Madden with Outperform Rating

Related Posts

Stifel Maintains Buy on Apellis Pharmaceuticals, Raises Price Target to $75

Nano Dimension Announces Preliminary Q2/2023 Revenue Of $14.8M, A 33% Increase YoY

Chembio Diagnostics Files For Potential Stock Offering, Size Not Disclosed

Friend.Tech Launches Version 2 With Native Token Airdrop, But Not Everything Goes According To Plan…